ArticleJournal of behavioral and experimental finance2021
Immune or at-risk? Stock markets and the significance of the COVID-19 pandemic.
Article in Journal of behavioral and experimental finance, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Signed Connectedness Among Cryptocurrencies, NFTs, and Foreign Exchange Markets.Entropy (Basel, Switzerland) · 2026Article
- Corporate vulnerability in the US and China during COVID-19: A machine learning approach.Journal of economic asymmetries · 2023Article
- Does US full vaccination against COVID-19 immunize correspondingly S&P500 index: Evidence from the NARDL approach.Heliyon · 2023Article
- The sum of all SCARES COVID-19 sentiment and asset return.The Quarterly review of economics and finance : journal of the Midwest Economics Association · 2022Article
- Changes in social behavior and impacts of the COVID-19 pandemic on regional housing markets: Independence and risk.Journal of behavioral and experimental finance · 2022Article
- COVID-19 news and the US equity market interactions: An inspection through econometric and machine learning lens.Annals of operations research · 2022Article
- Stock market in the age of COVID19: Mere acclimatization or Stockholm syndrome?Journal of economic asymmetries · 2022Article
- Winners and losers from Pfizer and Biontech's vaccine announcement: Evidence from S&P 500 (Sub)sector indices.PloS one · 2022Article
- Sentiment and hype of business media topics and stock market returns during the COVID-19 pandemic.Journal of behavioral and experimental finance · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The closure of borders and traditional commerce due to the COVID-19 pandemic is expected to have a lasting financial impact. We determine whether the growth in COVID-19 affected index prices by examining equity markets in five regional epicentres, along with a 'global' index. We also investigate the impact of COVID-19 after controlling for investor sentiment, credit risk, liquidity risk, safe-haven asset demand and the price of oil. Despite controlling for these traditional market drivers, the daily totals of COVID-19 cases nevertheless explained index price changes in Spain, Italy, the United Kingdom and the United States. Similar results were not observed in China, the origin of the virus, nor in the 'global' index (MSCI World). Our results suggest that early interventions (China) and the spatiotemporal nature of pandemic epicentres (World) should be considered by governments, regulators and relevant stakeholders in the event of future COVID-19 'waves' or further extreme societal disruptions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.